Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours

被引：0
|
作者：
Daniel M. Huse
Margaret von Mehren
Gregory Lenhart
Heikki Joensuu
Charles Blanke
Weiwei Feng
Stan Finkelstein
George Demetri
机构：
[1] Thomson Medstat,Department of Medical Oncology
[2] Fox Chase Cancer Center,Department of Oncology, Helsinki University
[3] Helsinki University Central Hospital,MIT Sloan School of Management
[4] The Oregon Health and Science University Cancer Institute,Dana
[5] Novartis Pharmaceuticals Corporation,Farber Cancer Institute
[6] Oncology,undefined
[7] Harvard-MIT Division of Health Sciences and Technology,undefined
[8] Center for Sarcoma and Bone Oncology,undefined
来源：
Clinical Drug Investigation | 2007年 / 27卷
关键词：
Pancreatic Cancer; Imatinib; National Comprehensive Cancer Network; National Comprehensive Cancer Network; Imatinib Mesylate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background and objective: Imatinib mesylate is the first effective therapy for advanced unresectable gastrointestinal stromal tumours (GIST). Adoption of this therapy in clinical practice is partly dependent on reimbursement by third-party payers in many countries. The objective of this study was to estimate the cost effectiveness of imatinib mesylate in the treatment of GIST.
引用
收藏
页码：85 / 93
页数：8
相关论文
共 50 条
  • [21] Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib
    Montemurro, M.
    Schoffski, P.
    Reichardt, P.
    Gelderblom, H.
    Schuette, J.
    Hartmann, J. T.
    von Moos, R.
    Seddon, B.
    Joensuu, H.
    Wendtner, C. M.
    Weber, E.
    Gruenwald, V.
    Roth, A.
    Leyvraz, S.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (13) : 2293 - 2297
  • [22] A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor
    Ben Ami, Eytan
    Demetri, George D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 571 - 578
  • [23] Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment
    Yeh, Chun-Nan
    Chen, Tsung-Wen
    Liu, Feng-Yuan
    Jan, Yi-Yin
    Chen, Miin-Fu
    LANGENBECKS ARCHIVES OF SURGERY, 2006, 391 (06) : 615 - 621
  • [24] Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment
    Chun-Nan Yeh
    Tsung-Wen Chen
    Feng-Yuan Liu
    Yi-Yin Jan
    Miin-Fu Chen
    Langenbeck's Archives of Surgery, 2006, 391 : 615 - 621
  • [25] Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost-effectiveness study
    Zuidema, Sander
    Desar, Ingrid M. E.
    van Erp, Nielka P.
    Kievit, Wietske
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (09) : 1994 - 2001
  • [26] Gastrointestinal stromal tumours: Clinical overview, surgery and recent advances in imatinib mesylate therapy
    Samelis, G. F.
    Ekmektzoglou, K. A.
    Zografos, G. C.
    EJSO, 2007, 33 (08): : 942 - 950
  • [27] Imatinib mesylate (IM) in locally advanced and metastatic gastrointestinal stromal tumours (GISTs): Cambridge GIST study group experience
    Bulusu, VR
    Basu, BJ
    Hatcher, H
    Parkinson, C
    Sherbourne, K
    Earl, HM
    Save, VE
    Carroll, NR
    Hardwick, RH
    Balan, K
    ANNALS OF ONCOLOGY, 2005, 16 : 311 - 311
  • [28] Efficacy of imatinib mesylate in from gastrointestinal stromal
    Fiorentini, G
    Bernardeschi, P
    De Simone, M
    Rossi, S
    Dentico, P
    Biancalani, M
    Scuderi, S
    Vaira, M
    Palomba, A
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (04): : 13 - 16
  • [29] Survival benefit of imatinib mesylate on patients with advanced gastrointestinal stromal tumors (GIST)
    Lin, M. T.
    Hu, T. H.
    Lin, J. W.
    Wang, C. C.
    Rau, K. M.
    Changchien, C. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A44 - A44
  • [30] Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor
    Hou, Ying-Yong
    Zhou, Yang
    Lu, Shao-Hua
    Qi, Wei-Dong
    Xu, Cheng
    Hou, Jun
    Tan, Yun-Shan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (15) : 1910 - 1913
12345